GlassScriptPhysician profile
Vivek K Mehta
NPI 1417970252
$120,012.16
in general payments reported to CMS, 2019-2025
11 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $28K · 2021: $127 · 2022: $40K · 2023: $556 · 2024: $30K · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $2,099 · Food and Beverage: $875 · Entertainment: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,600.00 |
| Travel and Lodging | $2,099.39 |
| Food and Beverage | $874.51 |
| Entertainment | $181.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $96,539.70 | 2019-2025 | Elekta Medical Linear Accelerator |
| Advanced Accelerator Applications | $14,133.31 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $5,850.00 | 2019 | |
| Reflexion Medical, INC. | $1,148.44 | 2022-2023 | Reflexion Medical Radiotherapy System |
| Astrazeneca Uk Limited | $1,050.00 | 2019 | |
| Varian Medical Systems, INC. | $542.95 | 2020 | |
| Siemens Medical Solutions USA, INC. | $419.72 | 2022-2025 | Aria Radiation Therapy Management Software, Varian Ethos Treatment Planning, Edge |
| Abbott Laboratories | $166.29 | 2022 | |
| Medtronic, INC. | $113.23 | 2021 | |
| Sirtex Medical INC | $34.96 | 2025 | Sir-Spheres Microspheres |
| Allergan, INC. | $13.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.